The antiviral remdesivir is priced “well below” the projected value of most patient treatments, the drugmaker says. Others claim the cost is too high, considering that its development was partly taxpayer...
Muscle relaxant prescriptions have tripled for older adults, investigators find
By
Alicia Lasek
Jun 30, 2020
Clinicians may be prescribing the drugs as an opioid alternative for chronic pain management, propose the researchers. Opioids are often prescribed simultaneously, they found.
CDC: Full-time, trained staff needed to oversee COVID-19 prevention
By
Alicia Lasek
Jun 30, 2020
Nursing facilities with 100 or more residents and operators who provide dialysis or ventilator care should have at least one trained infection preventionist on-site, according to new federal guidance.
Clinical Briefs for Tuesday, June 30
By
Alicia Lasek
Jun 30, 2020
Owners take rare step to isolate with residents during pandemic … Causal link found between air pollution and elders’ increased mortality … Gene study shows how Alzheimer’s affects genders differently...
Lower-rated facilities get more Alzheimer’s admissions: study
By
Alicia Lasek
Jun 29, 2020
Highly rated operations had 3% fewer newly admitted residents with Alzheimer’s. CNA wages and Medicaid add-ons may play a role in the findings, report investigators.
CDC expands list of chronic conditions that can make COVID-19 worse
By
Alicia Lasek
Jun 29, 2020
Hypertension by itself is no longer on the list of conditions linked to highest severity risk. Meanwhile, the agency’s director warns that the U.S. remains in a shape-shifting viral ‘first...
Clinical Briefs for Monday, June 29
By
Alicia Lasek
Jun 28, 2020
COVID-19 may lead to strokes, a dementia-like syndrome, and psychiatric conditions, survey finds … New gene may drive earliest Alzheimer’s brain changes … Diabetes-related amputations on rise in...
Clinical Briefs for Friday, June 26
By
Alicia Lasek
Jun 26, 2020
Breaking news: CMS orders resumption of nursing home staffing data collection, updates star-rating plans … Gilead’s remdesivir set to become Europe’s first COVID-19 therapy … High-dose...
Common drug used to slow kidney disease found to be ineffective
By
Alicia Lasek
Jun 26, 2020
The drug allopurinol does not slow the rate of worsening kidney disease, despite being used in up to 20% of kidney patients, a clinical trial has found.
Bi-monthly virtual conference to share COVID-19 best practices
By
Alicia Lasek
Jun 26, 2020
The Green House Project will convene long-term care experts to share “proven protocols and lessons learned.” Participants will have a chance to receive feedback regarding their own cases and questions.